Trial Profile
A phase I clinical pharmacology study of SJP-0125
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2019
Price :
$35
*
At a glance
- Drugs Brimonidine/brinzolamide (Primary) ; Brimonidine; Brinzolamide
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Pharmacokinetics
- Sponsors Senju Pharmaceutical
- 14 Feb 2019 Status changed from not yet recruiting to completed.
- 15 Mar 2018 New trial record